| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.33B | -8.5% |
| Cost of Revenue | $1.41B | -11.4% |
| Gross Profit | $918.5M | -3.6% |
| R&D Expense | $68.1M | +39.5% |
| SG&A Expense | $596.8M | +3.1% |
| Operating Income | $173.6M | -46.6% |
| Pre-tax Income | $129.1M | -52.5% |
| Income Tax | $13.0M | -84.8% |
| Net Income | $118.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $289.3M | +8.9% |
| Accounts Receivable | $461.8M | +1.3% |
| Inventory | $298.9M | +2.8% |
| Current Assets | $1.20B | +0.7% |
| Total Assets | $4.97B | +1.4% |
| Current Liabilities | $369.4M | +7.3% |
| Long-term Debt | $1.95B | +1.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $52.7M | +10.3% |
| Investing Cash Flow | -$250.2M | -232.7% |
| Financing Cash Flow | -$58.7M | +78.7% |
| -36.9% |
| EPS (Basic) | $0.49 | -35.5% |
| EPS (Diluted) | $0.49 | -35.5% |
| Total Liabilities |
| $2.63B |
| +2.9% |
| Stockholders' Equity | $2.33B | -0.2% |